Skip to main content
. 2023 Jul 30;29(3):378–387. doi: 10.5056/jnm22152

Table 4.

Treatment and Emergency Hospitalization Details and Outcomes

Treatment CIPO patients (n = 74)
Dietary therapy
Dietary restrictions, effective 41 (55)
Combined with TPN 24 (32)
Use of ED at initial consultation 37 (50)
Use of ED from onset of symptoms 74 (100)
Patients who could not tolerate ED 60 (81)
Exacerbation of abdominal bloating with ED 39 (53)
SIBO(+) 23 (59)
SIBO(–) 6 (15)
Intestinal sterilization 51 (69)
Period from onset to the start of intestinal sterilization (yr) 7 ± 9
Effective 33 (65)
Metronidazole 28 (85)
Vancomycin 3 (9)
Rifaximin 1 (3)
Ciprofloxacin 1 (3)
Adverse effects of antibiotics requiring hospitalization
History of metronidazole 38 (51)
Metronidazole induced encephalopathy 5 (13)
Decompression therapy
Period from onset to the start of decompression therapy (yr) 4 ± 5
PEG-J 18 (24)
PEG-J effective rate 15 (83)
Enterostomy 2 (3)
Surgical therapy and transplantation 0 (0)
Opioid use 7 (9)
Opioid effectiveness 4 (57)
Tramadol 3 (43)
Tramadol + acetaminophen 1 (14)
Oxycodone 2 (29)
Buprenorphine transdermal preparation 1 (14)
Number of emergency hospitalizations 5.8 ± 7.6
Exacerbation of abdominal bloating 47 (78)
Dehydration 4 (7)
Infection 2 (3)
Port occlusion 2 (3)
History of ≥ 6 emergency hospitalizations 27 (36)
TPN user 11 (41)
PEG-J user 8 (30)
Patient outcomes
Death (person-years) 11.5
Age at death (yr) 60 ± 14
Period from onset to the start of death (yr) 15 ± 14
Death rate 9 (12)
TPN users 6 (67)
PEG-J users 4 (44)
Infections 5 (56)
Suicides 2 (22)
Respiratory failure 1 (11)
Cancer 1 (11)

CIPO, chronic intestinal pseudo-obstruction; TPN, total parenteral nutrition; ED, elemental diet; SIBO, small intestinal bacterial overgrowth; PEG-J, Percutaneous endoscopic gastro-jejunostomy.

Data are shown as n (%) or mean ± SD.